View in EDS PDF Full Text

Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach: Anti-EBV Drugs for MS: V. Li et al.

Saved in:
Bibliographic Details
Title: Repurposing Licensed Drugs with Activity Against Epstein–Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach: Anti-EBV Drugs for MS: V. Li et al.
Authors: Li, Vivien1 (AUTHOR), McKay, Fiona C.2 (AUTHOR) fiona.mckay@msaustralia.org.au, Tscharke, David C.3 (AUTHOR), Smith, Corey4 (AUTHOR), Khanna, Rajiv4 (AUTHOR), Lechner-Scott, Jeannette5,6 (AUTHOR), Rawlinson, William D.7 (AUTHOR), Lloyd, Andrew R.8 (AUTHOR), Taylor, Bruce V.9 (AUTHOR), Morahan, Julia M.2 (AUTHOR), Steinman, Lawrence10 (AUTHOR), Giovannoni, Gavin11 (AUTHOR), Bar-Or, Amit12 (AUTHOR), Levy, Michael13 (AUTHOR), Drosu, Natalia13 (AUTHOR), Potter, Andrew2 (AUTHOR), Caswell, Nigel14 (AUTHOR), Smith, Lynne14 (AUTHOR), Brady, Erin C.14 (AUTHOR), Frost, Bruce14 (AUTHOR)
Source: CNS Drugs. Mar2025, Vol. 39 Issue 3, p305-320.
Database: SPORTDiscus with Full Text
Description
ISSN:11727047
DOI:10.1007/s40263-024-01153-5